ABSTRACT
Like many other aspects of sport, the discussion and evidence around managing drugs in sport tends to default to elite male sport. For example, Aubel and Ohl’s (2014) discussion of how doping is managed in cycling did so from the perspective of male professional cycling. This has seen discussion and evidence about the management of drugs for other versions of sport ignored. Ignoring other versions of sport may violate the obligations imposed by the pursuit of corporate social responsibility (CSR) in sport (see Chapter 1), and therefore undermine the ability to manage integrity in sport. The management of drugs in three other versions of sport is therefore considered: women’s sport, children’s sport and non-elite sport. The consideration of other versions of sport suggests that drug control-led integrity management for sport may need to specifically account for variation in how drugs and drug control are experienced across women’s, children’s and non-elite sport.
